Alexion Pharmaceuticals
Dan Segal, MBA, serves as the Associate Director of National Sales Operations and Field Training Lead at Alexion Pharmaceuticals, Inc., with a focus on the Metabolic Business Unit. Since April 2017, Dan has excelled in field excellence and strategy across various rare genetic disorders, receiving multiple accolades including the 2023 Excellence Award and the GOAT Award for training initiatives. Dan has a robust background in sales and training, previously holding roles such as Regional Account Manager and East Region Metabolic RAM Liaison, where impactful educational programs and strategic operations were developed to enhance the knowledge of healthcare professionals about rare diseases. Prior experience encompasses significant positions in sales training and management at companies like Ortho Dermatologics and Novartis Pharmaceuticals, with a solid educational foundation highlighted by an M.B.A. from the University of Scranton and a Bachelor's degree in Economics from the University at Albany.
This person is not in any teams
This person is not in any offices
Alexion Pharmaceuticals
44 followers
Alexion Pharmaceuticals, Inc. is a biopharmaceutical company, which is engaged in the discovery, development and commercialization of biologic therapeutic products aimed at treating patients with severe and life-threatening disease states, including hematologic, kidney and neurologic diseases, transplant rejection, cancer and autoimmune disorders.